The Biomarker Market is predicted to reach US$ ~ 119.87 by 2030 from US$ ~ 42.20 in 2021, and to grow at a CAGR of ~ 12.30% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2020. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Type (Safety, Application, Validation, Surrogate, Prognostic), Application (Diagnostics, Drug Discovery, Development, Clinical Trials, Personalized Medicine), Diseases (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Abbott Laboratories, F. Hoffmann La-Roche Ltd., Epigenomics A.G, General Electric, and Johnson and Johnson. Inc, Thermo Fisher Scientific, Inc., QIAGEN NV, Siemens Healthineers AG, Bio-Rad Laboratories, Enzo Biochem, Inc., Diametra, and Signosis, Inc. among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Biomarker Market - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Biomarker Market - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Biomarker Market - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Biomarker Market - ANALYSIS & FORECAST, BY REGION
North America Biomarker Market
1. North America Biomarker Market, by Country
1. US
2. Canada
1. North America Biomarker Market, by Product
2. North America Biomarker Market, by Type
3. North America Biomarker Market, by Gender
4. North America Biomarker Market, by Sales Channel
3. Europe Biomarker Market
1. Europe Biomarker Market, by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Biomarker Market, by Product
3. Europe Biomarker Market, by Type
4. Europe Biomarker Market, by Gender
5. Europe Biomarker Market, by Sales Channel
4. Asia Pacific Biomarker Market
1. Asia Pacific Biomarker Market, by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Biomarker Market, by product
3. Asia Pacific Biomarker Market, by Type
4. Asia Pacific Biomarker Market, by Gender
5. Asia Pacific Biomarker Market, by Sales Channel
5. Rest of the World Biomarker Market
1. Rest of the World Biomarker Market, by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Biomarker Market, by Product
3. Rest of the World Biomarker Market, by Type
4. Rest of the World Biomarker Market, by Gender
5. Rest of the World Biomarker Market, by Sales Channel
2. COMPANY PROFILES
Company 1, Company 10
The Voice Biomarker Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Alpha-Fetoprotein (AFP) Biomarker Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Biomarker Assays Development Support Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...
The Pharmacodynamic Biomarker Assay Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
Overview of the Global Biomarker Clinical Phase Outsourcing Services Market:
The report discusses everything a marketer requires before investing in the global Biomarker Clinical Phase Outsourcing Services Market du...
Overview of the Global Biomarker Discovery Outsourcing Services Market:
The report discusses everything a marketer requires before investing in the global Biomarker Discovery Outsourcing Services Market during the f...
The global Prostate Cancer Biomarker market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in...
The global ST2 Biomarker market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field ...
The global Biomarker Detection Systems market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players ...
The global Cancer Biomarker market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fie...